Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intraocular pressure (IOP) refers to the fluid pressure inside the eye. It results from the balance between production and drainage of aqueous humor by structures such as the ciliary body and its drainage through pathways including the trabecular meshwork and uveoscleral outflow routes. Normal values range from about 10–20 mmHg; sustained elevation increases risk for glaucoma—a leading cause of irreversible blindness—while abnormally low pressures can compromise ocular structure and vision stability. While many therapies aim at lowering elevated IOP in diseases like glaucoma by targeting specific molecules or cellular processes within these regulatory systems, intraocular pressure itself is not considered a direct drug target but rather an important clinical endpoint reflecting underlying biological activity[1][2][3].
Drugs affecting intraocular pressure act by modulating aqueous humor inflow (production) or outflow (drainage) through mechanisms involving the ciliary body epithelium, trabecular meshwork contractility, and Schlemm’s canal function.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intraocular pressure (IOP).